文献速递胃肠外科

美国住院腹腔镜Heller肌切开术与经口内镜下肌切开术围术期结局比较

Perioperative outcomes of inpatient laparoscopic Heller myotomy and per-oral endoscopic myotomy in the United States.
PubMed 文献 · Surgery · 2021-11-10

基于美国全国住院患者样本(2015年10月至2018年12月)的横断面回顾性分析,比较腹腔镜Heller肌切开术(n=9,555)与经口内镜下肌切开术(n=1,715)的围术期结局。经口内镜下肌切开术总体不良事件率更高(24.8% vs 13.3%,P<.001),但住院时间和费用相似。腹腔镜Heller肌切开术围术期不良事件率更低。

要点

  • 经口内镜下肌切开术总体不良事件率高于腹腔镜Heller肌切开术(24.8% vs 13.3%,P<.001)。
  • 腹腔镜Heller肌切开术同期抗反流手术比例更高(72.8% vs 15.5%,P<.001)。
  • 两种手术住院时间与费用相似,死亡率相似。

核心结论

  • 在全国数据库回顾中,腹腔镜Heller肌切开术围术期不良事件率低于经口内镜下肌切开术,且住院时间与费用相似。
  • 在美国,对于远端食管和下食管括约肌的肌切开术,腹腔镜Heller肌切开术仍是比经口内镜下肌切开术更安全的手术。

研究设计与样本

  • 横断面回顾性分析,使用美国全国住院患者样本(National Inpatient Sample)2015年10月至2018年12月的住院记录。
  • 共估计11,270例患者接受腹腔镜Heller肌切开术(n=9,555)或经口内镜下肌切开术(n=1,715)。
  • 比较患者与医院特征、同期抗反流手术、围术期不良事件(任何不良事件及与延长住院≥3天相关的不良事件)、死亡率、住院时间和费用,并用逻辑回归评估与不良事件独立相关的因素。

主要发现

  • 两组人口学特征和合并症无显著差异。
  • 腹腔镜Heller肌切开术组同期抗反流手术更常见(72.8% vs 15.5%,P<.001)。
  • 经口内镜下肌切开术组总体不良事件率更高(24.8% vs 13.3%,P<.001),死亡率相似。
  • 经口内镜下肌切开术组与延长住院≥3天相关的不良事件率更高(16.6% vs 9.3%,P<.001),感染性不良事件(8.2% vs 3.5%,P<.001)、胃肠道出血(5.8% vs 3.4%,P=.04)、意外损伤(5.5% vs 3%,P=.03)和胸部不良事件(9% vs 4.5%,P<.01)均更高。
  • 研究期间两种手术的不良事件率保持相似;住院时间(腹腔镜Heller肌切开术3.2±0.1天 vs 经口内镜下肌切开术3.7±0.3天,P=.17)和费用(15,471±406美元 vs 15,146±1,308美元,P=.82)相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Per-oral endoscopic myotomy is an alternative to pneumatic dilation and laparoscopic Heller myotomy to treat lower esophageal sphincter diseases. Laparoscopic Heller myotomy and per-oral endoscopic myotomy perioperative outcomes data come from relatively small retrospective series and 1 randomized trial. We aimed to estimate the number of inpatient procedures performed in the United States and compare perioperative outcomes and costs of laparoscopic Heller myotomy and per-oral endoscopic myotomy using a nationally representative database. METHODS: Cross-sectional retrospective analysis of hospital admissions for laparoscopic Heller myotomy or per-oral endoscopic myotomy from October 2015 through December 2018 in the National Inpatient Sample. Patient and hospital characteristics, concurrent antireflux procedures, perioperative adverse events (any adverse event and those associated with extended length of stay ≥3 days), mortality, length of stay, and costs were compared. Logistic regression evaluated factors independently associated with adverse events. RESULTS: An estimated 11,270 patients had laparoscopic Heller myotomy (n = 9,555) or per-oral endoscopic myotomy (n = 1,715) without significant differences in demographics and comorbidities. A concurrent anti-reflux procedure was more frequent with laparoscopic Heller myotomy (72.8% vs 15.5%, P < .001). Overall adverse event rate was higher with per-oral endoscopic myotomy (13.3% vs 24.8%, P < .001), and mortality was similar. Per-oral endoscopic myotomy had higher rates of adverse events associated with extended length of stay (9.3% vs 16.6%, P < .001), infectious adverse events (3.5% vs 8.2%, P < .001), gastrointestinal bleeding (3.4% vs 5.8%, P = .04), accidental injuries (3% vs 5.5%, P = .03), and thoracic adverse events (4.5% vs 9%, P < .01). Rates of adverse events of both procedures remained similar during the years of the study. Per-oral endoscopic myotomy was independently associated with adverse events. Length of stay (laparoscopic Heller myotomy: 3.2 ± 0.1 vs per-oral endoscopic myotomy: 3.7 ± 0.3 days, P = .17) and costs (laparoscopic Heller myotomy: $15,471 ± 406 vs per-oral endoscopic myotomy: $15,146 ± 1,308, P = .82) were similar. CONCLUSION: In this national database review, laparoscopic Heller myotomy had a lower rate of perioperative adverse events at similar length of stay and costs than per-oral endoscopic myotomy. Laparoscopic Heller myotomy remains a safer procedure than per-oral endoscopic myotomy for a myotomy of the distal esophagus and lower esophageal sphincter in the United States.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Khoraki J, Campos GM, Alwatari Y, et al. Perioperative outcomes of inpatient laparoscopic Heller myotomy and per-oral endoscopic myotomy in the United States. Surgery. 2021. PMID: 34774290. doi:10.1016/j.surg.2021.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。